<DOC>
	<DOCNO>NCT01235884</DOCNO>
	<brief_summary>Aim study . To evaluate L. reuteri DSM 17938 supplementation since first day life reduce onset gaseous colic neonate onset minor digestive disorder regurgitation constipation . Study Design . Double blind , randomize , control , multicenter study . 492 neonate 37-42 gestational age , breast formula feed , receive L. reuteri 5 drop ( 1x108 CFU ) daily placebo 28 day . After inclusion , baseline perform : - Paediatric visit - antropometric valutation - number daily cry minute , number regurgitation number daily evacuation The patient receive probiotics/placebo every day 28 day 29th repeat follow analysis : - Paediatric visit - antropometric valutation - number daily cry minute - number regurgitation - number evacuation Primary outcome : To define Lactobacillus reuteri supplementation reduce onset gaseous colic , regurgitation constipation . Inclusion criterion - neonate 37-42 week gestational age appropriate birth weight - Recruitment age : 7 day life - Informed consent sign Exclusion criterion - Presence gastrointestinal disease . - Use FANS , aspirin drug - Use antibiotic and/or PPIs e/o anti-H2 - Participation clinical trial</brief_summary>
	<brief_title>Prevention Minor Digestive Disorders Lactobacillus Reuteri Supplementation</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<criteria>neonate 3742 week gestational age appropriate birth weight Recruitment age : 7 day life Informed consent sign Presence gastrointestinal disease . Use FANS , aspirin drug Use antibiotic and/or PPIs e/o antiH2 Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Days</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>gaseous colic , regurgitation constipation</keyword>
</DOC>